News Search

Category: School of Medicine

Penn spinout Neuralert Technologies’ stroke detection wristband selected for TIME’s List of the Best Inventions of 2022

The lightweight, non-invasive wristband device can detect the stroke symptoms in as little as 15 minutes.

Emily Whitehead’s CAR-T Cell Therapy Journey Featured on CBS

CBS This Morning recently featured a story about Emily Whitehead, the first pediatric patient to receive Penn-invented CAR T cell therapy to fight cancer.

Drew Weismann Speaks on the Future of mRNA Technology in Bloomberg’s “The Big Take” Podcast

Weissman talks about his discovery and the impact of mRNA technology on the development of therapies for flu, cancer and rare genetic diseases.

PCI Team Member and Penn Medicine Featured in Washington Post

Carter Caldwell, Director of the Penn Medicine Co-Investment Program, was featured in the Washington Post’s Medical Mysteries column which described his journey following life-changing brain surgery.

Penn Medicine and Candel Therapeutics partner to pursue potential solid tumor CAR T-cell therapy

The University of Pennsylvania’s Center for Cellular Immunotherapies, led by cell therapy pioneer Dr. Carl June, has entered into a cancer treatment collaboration with Candel Therapeutics.

Weissman Lab is Working on New Type of Vaccines to Protect Against All Coronaviruses

The Weissman Lab is working towards developing vaccines that not only target multiple COVID variants, but also multiple types of coronaviruses.

Penn spinout Capstan Therapeutics Launches with Goal of Incorporating mRNA into CAR-T Cell Therapy

This new approach to CAR-T therapy will involve mRNA therapy that directs cells in the body to make proteins to prevent or fight disease.

Tech of the Month: AI-Powered Optical Tool for Fluorescence-Guided Oncological Surgery

This tool provides immediate and accurate tumor identification without the frozen section staining process normally required, saving over 30 minutes and thousands of dollars per tumor per operation.

Jim Wilson Speaks on What’s Next for Cell and Gene Therapy in Philadelphia

On September 8, Jim Wilson, director of Penn Medicine's gene therapy program and director of Penn's orphan disease center. sat down with health care reporter John George for a wide-ranging discussion.

Penn Medicine to Conduct New Clinical Trial to Evaluate Safety and Efficacy of Chewing Gum Designed by School of Dental Medicine Researchers to Trap SARS-CoV-2 in Saliva

The trial will recruit participants from a pool of Penn Medicine employees whose responses to the PennOpen Pass screening system indicate that they may be infected with COVID-19.


Skip to content